Geode Capital Management
FOLD

Geode Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Geode Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$123M Buy
8,535,918
+1,190,651
+16% +$17.1M 0.01% 957
2025
Q4 		$105M Buy
7,345,267
+246,174
+3% +$2.42M 0.01% 1052
2025
Q3 		$56M Buy
7,099,093
+392,604
+6% +$2.79M ﹤0.01% 1402
2025
Q2 		$38.4M Sell
6,706,489
-57,278
-0.8% -$370K ﹤0.01% 1568
2025
Q1 		$55.2M Buy
6,763,767
+152,835
+2% +$1.41M ﹤0.01% 1326
2024
Q4 		$62.3M Buy
6,610,932
+11,061
+0.2% +$115K ﹤0.01% 1295
2024
Q3 		$70.5M Buy
6,599,871
+80,926
+1% +$881K 0.01% 1229
2024
Q2 		$64.7M Buy
6,518,945
+308,209
+5% +$3.16M 0.01% 1178
2024
Q1 		$73.2M Buy
6,210,736
+259,441
+4% +$3.32M 0.01% 1113
2023
Q4 		$84.5M Buy
5,951,295
+345,129
+6% +$3.92M 0.01% 971
2023
Q3 		$68.2M Buy
5,606,166
+210,560
+4% +$2.72M 0.01% 1017
2023
Q2 		$67.8M Buy
5,395,606
+253,199
+5% +$3M 0.01% 1031
2023
Q1 		$57M Buy
5,142,407
+251,979
+5% +$3.11M 0.01% 1097
2022
Q4 		$59.7M Buy
4,890,428
+167,542
+4% +$1.89M 0.01% 1032
2022
Q3 		$49.3M Buy
4,722,886
+63,632
+1% +$709K 0.01% 1096
2022
Q2 		$50M Buy
4,659,254
+143,003
+3% +$1.18M 0.01% 1120
2022
Q1 		$42.8M Sell
4,516,251
-210,482
-4% -$1.97M 0.01% 1368
2021
Q4 		$54.6M Buy
4,726,733
+275,911
+6% +$3.07M 0.01% 1241
2021
Q3 		$42.5M Sell
4,450,822
-195,109
-4% -$2M 0.01% 1412
2021
Q2 		$44.8M Buy
4,645,931
+270,704
+6% +$2.64M 0.01% 1400
2021
Q1 		$43.2M Buy
4,375,227
+316,124
+8% +$4.89M 0.01% 1345
2020
Q4 		$93.7M Buy
4,059,103
+219,012
+6% +$4.48M 0.02% 727
2020
Q3 		$54.2M Sell
3,840,091
-33,299
-0.9% -$485K 0.01% 868
2020
Q2 		$58.4M Buy
3,873,390
+63,555
+2% +$774K 0.01% 814
2020
Q1 		$35.2M Buy
3,809,835
+303,764
+9% +$2.89M 0.01% 946
2019
Q4 		$34.1M Buy
3,506,071
+146,857
+4% +$1.34M 0.01% 1195
2019
Q3 		$26.9M Buy
3,359,214
+182,723
+6% +$1.98M 0.01% 1283
2019
Q2 		$39.6M Buy
3,176,491
+452,284
+17% +$5.74M 0.01% 1020
2019
Q1 		$37M Buy
2,724,207
+540,528
+25% +$6.6M 0.01% 1002
2018
Q4 		$20.9M Buy
2,183,679
+180,938
+9% +$1.99M 0.01% 1243
2018
Q3 		$24.2M Buy
2,002,741
+81,299
+4% +$1.14M 0.01% 1268
2018
Q2 		$30M Buy
1,921,442
+179,629
+10% +$2.72M 0.01% 1067
2018
Q1 		$26.2M Buy
1,741,813
+175,552
+11% +$2.67M 0.01% 1073
2017
Q4 		$22.5M Buy
1,566,261
+93,172
+6% +$1.28M 0.01% 1172
2017
Q3 		$22.2M Buy
1,473,089
+222,064
+18% +$2.94M 0.01% 1156
2017
Q2 		$12.6M Buy
1,251,025
+83,669
+7% +$673K 0.01% 1507
2017
Q1 		$8.32M Buy
1,167,356
+52,003
+5% +$329K ﹤0.01% 1744
2016
Q4 		$5.54M Buy
1,115,353
+46,004
+4% +$318K ﹤0.01% 2006
2016
Q3 		$7.91M Buy
1,069,349
+212,602
+25% +$1.44M ﹤0.01% 1651
2016
Q2 		$4.68M Buy
856,747
+15,290
+2% +$107K ﹤0.01% 1958
2016
Q1 		$7.11K Buy
841,457
+33,449
+4% +$237K ﹤0.01% 1624
2015
Q4 		$7.84M Buy
808,008
+58,610
+8% +$528K ﹤0.01% 1548
2015
Q3 		$10.5M Buy
749,398
+48,142
+7% +$755K 0.01% 1311
2015
Q2 		$9.92M Buy
701,256
+293,525
+72% +$3.53M 0.01% 1419
2015
Q1 		$4.44M Buy
407,731
+10,283
+3% +$90.6K ﹤0.01% 1928
2014
Q4 		$3.31M Buy
397,448
+151,867
+62% +$1.04M ﹤0.01% 2085
2014
Q3 		$1.46M Buy
245,581
+107,907
+78% +$565K ﹤0.01% 2558
2014
Q2 		$459K Sell
137,674
-22,406
-14% -$52.6K ﹤0.01% 3203
2014
Q1 		$331K Buy
160,080
+4,976
+3% +$12.4K ﹤0.01% 3319
2013
Q4 		$364K Buy
155,104
+2,985
+2% +$6.55K ﹤0.01% 3212
2013
Q3 		$353K Buy
152,119
+3,619
+2% +$9.08K ﹤0.01% 3096
2013
Q2 		$346K Buy
+148,500
New +$456K ﹤0.01% 3031

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Geode Capital Management's FOLD Position: Q1 2026 in Review

Geode Capital Management increased its Amicus Therapeutics (FOLD) stake by 16% in Q1 2026, buying an estimated $17.1M and bringing the position to 8,535,918 shares worth $123M. The position accounts for 0.01% of the portfolio, ranked #957.

Geode Capital Management first reported a position in FOLD in Q2 2013 and has held it in 52 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Geode Capital Management held 8,535,918 shares of Amicus Therapeutics worth $123M as of Q1 2026.
  • Geode Capital Management bought 1,190,651 Amicus Therapeutics shares in Q1 2026, an estimated $17.1M.
  • Amicus Therapeutics made up 0.01% of Geode Capital Management's portfolio in Q1 2026, its #957 holding.
  • Geode Capital Management first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.